Breast Cancer

HER 2 Negative Breast Cancer

Female, 45 years

Patient Internal ID: 495720

ICD-10 code

C50.5 Malignant Neoplasm of Lower Outer Quadrant of Breast

Diagnosis (Incl. Metastases/Stage) and Year

June 2022
Invasive Poorly Differentiated Ductal Carcinoma of the Right Breast G3 pT2pN0(sn)M0 Stage II A, LVI-0, ER (+), PR (-), HER2(1+), Ki67 – 3% (up to 10% in Hot Spots).

Previous Treatment

Surgery, Hormone Therapy (Tamoxifen), Radiation Therapy.

Prognosis and Survival Expectation

Estrogen-Receptor Positive Breast Cancer has a median overall survival (OS) of 37 months. The overall survival rate of Breast Cancer patients on Estrogen Positive  Receptors was 41.51%.

Treatment Provided

Autologous DCV (5 doses) and CIK (4 doses) over a period of 4 months.

Patient Survival/Condition and Year
Date of Review: 30/12/2023

The patient has survived for 18 months since the diagnosis so far. No signs of disease progression.
The patient continues treatment with Tamoxifen and has regular follow-up visits.